{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0007576,73,MONDO:0007576,103,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0007576","source":"MONDO:0007576|esophageal cancer","targets":["NCT00333099|INEC Study: Immuno-modulating Enteral Nutrition in Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00365508|Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking|COMPLETED|PHASE4|INTERVENTIONAL","NCT00538421|Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT00666978|Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking|COMPLETED|PHASE4|INTERVENTIONAL","NCT00754468|Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00790140|Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00911092|Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT01038154|Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01398982|TAP Block in DIEP or Free MS-TRAM Donor Site: A RCT|COMPLETED|PHASE4|INTERVENTIONAL","NCT01416077|Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection|COMPLETED|PHASE4|INTERVENTIONAL","NCT01927328|Iron Replacement in Oesophagogastric Neoplasia|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01962272|The Effect of Nutritional Counseling for Cancer Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT02042313|Postoperative Pain Management After Minimally Invasive Esophagectomy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02320734|Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy|COMPLETED|PHASE4|INTERVENTIONAL","NCT03384511|The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.|COMPLETED|PHASE4|INTERVENTIONAL","NCT03413436|Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma|COMPLETED|PHASE4|INTERVENTIONAL","NCT03642093|HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04269369|Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05183126|Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer|RECRUITING|PHASE4|INTERVENTIONAL","NCT06437288|Hematoporphyrin Photodynamic Therapy for Esophageal Cancer|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT07124351|Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)|RECRUITING|PHASE4|INTERVENTIONAL","NCT00002631|Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002883|Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002884|Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00002897|Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002930|PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00003118|Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|COMPLETED|PHASE3|INTERVENTIONAL","NCT00020787|Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00041262|Combination Chemotherapy in Treating Patients With Esophageal Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00047112|Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00052910|Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00160875|Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00165061|Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00193817|Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00193882|Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00270166|The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00357682|A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00359645|Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population|COMPLETED|PHASE3|INTERVENTIONAL","NCT00387348|Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00416858|Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00509561|Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00525200|p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00655876|Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00665197|Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00686114|Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00861094|Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00978549|Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01032967|Surgery or Chemoradiation for Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01053182|Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet Approaches|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01054274|a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01107639|Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT01196390|Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01242124|Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01243398|Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT01249352|A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01348217|Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01404156|Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01446874|Prevention of Post-operative Pneumonia (POPP)|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT01544790|Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy|COMPLETED|PHASE3|INTERVENTIONAL","NCT01704690|Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT01726452|NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)|COMPLETED|PHASE3|INTERVENTIONAL","NCT01915693|ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study|COMPLETED|PHASE3|INTERVENTIONAL","NCT01998230|Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01998347|Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT02279134|Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT02326779|Low-dose Aspirin Therapy for Esophageal Cancer|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT02349412|Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers|COMPLETED|PHASE3|INTERVENTIONAL","NCT02448979|Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02461043|Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02465736|Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02556762|Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT02569242|Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT02570893|A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02741856|Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT02780921|Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02813967|S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT02853474|Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT02979691|Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT03002064|Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03070262|The Efficacy and Safety of Caffeic Acid for Esophageal Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03094351|Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03273686|Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03366883|Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03691090|Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT03708042|A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03731442|Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients|RECRUITING|PHASE3|INTERVENTIONAL","NCT04135664|Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma|RECRUITING|PHASE3|INTERVENTIONAL","NCT04237090|Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel|COMPLETED|PHASE3|INTERVENTIONAL","NCT04280822|Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma|RECRUITING|PHASE3|INTERVENTIONAL","NCT04415853|Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer|RECRUITING|PHASE3|INTERVENTIONAL","NCT04426955|Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT04513808|Total Intravenous Anesthesia and Recurrence Free Survival|RECRUITING|PHASE3|INTERVENTIONAL","NCT04540211|A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT04821778|Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer|RECRUITING|PHASE3|INTERVENTIONAL","NCT04821843|Neoadjuvant Treatment Modalities in Esophageal Cancer|RECRUITING|PHASE3|INTERVENTIONAL","NCT04871412|The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III|RECRUITING|PHASE3|INTERVENTIONAL","NCT05049681|Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell|UNKNOWN|PHASE3|INTERVENTIONAL","NCT05055648|PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy|RECRUITING|PHASE3|INTERVENTIONAL","NCT05188313|TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer|RECRUITING|PHASE3|INTERVENTIONAL","NCT05357846|PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)|RECRUITING|PHASE3|INTERVENTIONAL"]}]}